ICON Price to Book Ratio 2010-2023 | ICLR
Historical price to book ratio values for ICON (ICLR) over the last 10 years. The current price to book ratio for ICON as of April 15, 2024 is 2.67.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| ICON Price/Book Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | Book Value per Share | Price to Book Ratio |
| 2024-04-15 | 299.12 | 2.67 | |
| 2023-12-31 | 283.07 | $112.02 | 2.53 |
| 2023-09-30 | 246.25 | $108.82 | 2.26 |
| 2023-06-30 | 250.20 | $107.08 | 2.34 |
| 2023-03-31 | 213.59 | $105.63 | 2.02 |
| 2022-12-31 | 194.25 | $103.98 | 1.87 |
| 2022-09-30 | 183.78 | $100.91 | 1.82 |
| 2022-06-30 | 216.70 | $99.92 | 2.17 |
| 2022-03-31 | 243.22 | $99.26 | 2.45 |
| 2021-12-31 | 309.70 | $98.91 | 3.13 |
| 2021-09-30 | 262.02 | $97.90 | 2.68 |
| 2021-06-30 | 206.71 | $38.29 | 5.40 |
| 2021-03-31 | 196.37 | $36.59 | 5.37 |
| 2020-12-31 | 194.98 | $35.05 | 5.56 |
| 2020-09-30 | 191.09 | $32.42 | 5.89 |
| 2020-06-30 | 168.46 | $29.99 | 5.62 |
| 2020-03-31 | 136.00 | $28.83 | 4.72 |
| 2019-12-31 | 172.23 | $30.91 | 5.57 |
| 2019-09-30 | 147.34 | $28.66 | 5.14 |
| 2019-06-30 | 153.97 | $28.27 | 5.45 |
| 2019-03-31 | 136.58 | $26.35 | 5.18 |
| 2018-12-31 | 129.21 | $25.09 | 5.15 |
| 2018-09-30 | 153.75 | $24.51 | 6.27 |
| 2018-06-30 | 132.53 | $22.80 | 5.81 |
| 2018-03-31 | 118.14 | $22.40 | 5.27 |
| 2017-12-31 | 112.15 | $22.02 | 5.09 |
| 2017-09-30 | 113.88 | $20.82 | 5.47 |
| 2017-06-30 | 97.79 | $19.05 | 5.13 |
| 2017-03-31 | 79.72 | $17.56 | 4.54 |
| 2016-12-31 | 75.20 | $17.33 | 4.34 |
| 2016-09-30 | 77.37 | $17.77 | 4.35 |
| 2016-06-30 | 70.01 | $16.41 | 4.27 |
| 2016-03-31 | 75.10 | $15.32 | 4.90 |
| 2015-12-31 | 77.70 | $13.88 | 5.60 |
| 2015-09-30 | 70.97 | $15.08 | 4.71 |
| 2015-06-30 | 67.30 | 0.00 | |
| 2015-03-31 | 70.53 | 0.00 | |
| 2014-12-31 | 50.99 | $15.81 | 3.23 |
| 2014-09-30 | 57.23 | 0.00 | |
| 2014-03-31 | 47.55 | 0.00 | |
| 2013-12-31 | 40.42 | $14.79 | 2.73 |
| 2013-09-30 | 40.93 | 0.00 | |
| 2013-06-30 | 35.43 | 0.00 | |
| 2013-03-31 | 32.29 | 0.00 | |
| 2012-12-31 | 27.76 | 0.00 | |
| 2014-06-30 | 47.11 | 0.00 | |
| 2012-09-30 | 24.37 | 0.00 | |
| 2012-06-30 | 22.53 | 0.00 | |
| 2012-03-31 | 21.22 | 0.00 | |
| 2011-12-31 | 17.11 | 0.00 | |
| 2011-09-30 | 16.08 | 0.00 | |
| 2011-06-30 | 23.56 | 0.00 | |
| 2011-03-31 | 21.59 | 0.00 | |
| 2010-12-31 | 21.90 | 0.00 | |
| 2010-09-30 | 21.62 | 0.00 | |
| 2010-06-30 | 28.89 | 0.00 | |
| 2010-03-31 | 26.41 | 0.00 | |
| 2009-12-31 | 21.73 | 0.00 | |
| 2009-09-30 | 24.49 | 0.00 | |
| 2009-06-30 | 21.58 | 0.00 | |
| 2009-03-31 | 16.15 | 0.00 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $24.676B | $8.120B |
| ICON plc is a global full service clinical research organisation. The company provides contract clinical research services to the pharmaceutical industry worldwide. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $116.371B | 15.10 |
| Cencora (COR) | United States | $46.721B | 18.65 |
| DiDi Global (DIDIY) | China | $22.638B | 0.00 |
| Avantor (AVTR) | United States | $16.760B | 23.09 |
| CochLear (CHEOY) | $13.599B | 0.00 | |
| Viatris (VTRS) | United States | $13.580B | 3.88 |
| Revvity (RVTY) | United States | $12.639B | 22.00 |
| Charles River Laboratories (CRL) | United States | $12.153B | 22.15 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $11.999B | 0.00 |
| Medpace Holdings (MEDP) | United States | $11.995B | 43.60 |
| Natera (NTRA) | United States | $10.919B | 0.00 |
| Solventum (SOLV) | $10.642B | 0.00 | |
| Amplifon S.p.A (AMFPF) | Italy | $7.290B | 37.01 |
| HealthEquity (HQY) | United States | $6.884B | 51.43 |
| Bausch + Lomb (BLCO) | Canada | $5.025B | 19.32 |
| Doximity (DOCS) | United States | $4.742B | 35.31 |
| Organon (OGN) | United States | $4.527B | 4.38 |
| Surgery Partners (SGRY) | United States | $3.250B | 30.20 |
| Progyny (PGNY) | United States | $3.249B | 54.53 |
| Sotera Health (SHC) | United States | $3.117B | 15.29 |
| Life Times (LTH) | United States | $2.838B | 31.37 |
| GoodRx Holdings (GDRX) | United States | $2.587B | 131.00 |
| Premier (PINC) | United States | $2.486B | 9.10 |
| Teladoc Health (TDOC) | United States | $2.294B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $2.163B | 7.00 |
| Agilon Health (AGL) | United States | $1.827B | 0.00 |
| BrightSpring Health Services (BTSG) | United States | $1.779B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.401B | 0.00 | |
| NovoCure (NVCR) | Jersey | $1.369B | 0.00 |
| Agiliti (AGTI) | United States | $1.365B | 22.31 |
| Alignment Healthcare (ALHC) | United States | $0.890B | 0.00 |
| Pediatrix Medical (MD) | United States | $0.771B | 7.97 |
| Embecta (EMBC) | United States | $0.610B | 4.03 |
| InnovAge Holding (INNV) | United States | $0.563B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.555B | 0.00 |
| Enhabit (EHAB) | United States | $0.523B | 47.41 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.515B | 0.00 |
| MultiPlan (MPLN) | United States | $0.496B | 0.00 |
| Beauty Health (SKIN) | United States | $0.439B | 0.00 |
| CareDx (CDNA) | United States | $0.425B | 0.00 |
| LifeMD (LFMD) | United States | $0.388B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.381B | 0.00 |
| DocGo (DCGO) | United States | $0.339B | 54.17 |
| Sera Prognostics (SERA) | United States | $0.326B | 0.00 |
| ModivCare (MODV) | United States | $0.319B | 4.23 |
| GeneDx Holdings (WGS) | United States | $0.257B | 0.00 |
| Sharecare (SHCR) | United States | $0.256B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.250B | 0.00 |
| Biodesix (BDSX) | United States | $0.121B | 0.00 |
| So-Young (SY) | China | $0.109B | 36.67 |
| Oncology Institute (TOI) | United States | $0.088B | 0.00 |
| Pono Capital Two (PTWO) | United States | $0.063B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.062B | 0.00 |
| NeueHealth (NEUE) | United States | $0.050B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.037B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.037B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.029B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.028B | 0.00 |
| Nutex Health (NUTX) | United States | $0.027B | 0.00 |
| DermTech (DMTK) | United States | $0.021B | 0.00 |
| OncoCyte (OCX) | United States | $0.021B | 0.00 |
| BIMI Medical (BIMI) | United States | $0.015B | 0.00 |
| Aesthetic Medical Hldngs Group (AIH) | China | $0.012B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.011B | 0.00 | |
| Intelligent Bio Solutions (INBS) | United States | $0.009B | 0.00 |
| TRxADE HEALTH (MEDS) | United States | $0.009B | 0.00 |
| OpGen (OPGN) | United States | $0.007B | 0.00 |
| XWELL (XWEL) | United States | $0.006B | 0.00 |
| Assure Holdings (IONM) | United States | $0.004B | 0.00 |
| NewGenIvf Group (NIVF) | Singapore | $0.003B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |
| ISpecimen (ISPC) | United States | $0.002B | 0.00 |